Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bristol-Myers Squibb
Bristol-Myers Squibb
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
770 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Aresma - Clinica Adventista Belgrano
Belgrano, Buenos Aires, Argentina
Recruiting - Fundacion Respirar
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
Recruiting - Instituto Argentino de Diagnostico Y Tratamiento
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
Recruiting - Local Institution - Unk043
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
Active, not recruiting - Local Institution - 007-436
Pergamino, Buenos Aires, Argentina
Not, yet, recruiting - Centro Oncologico Korben
San Pedro, Buenos Aires, Argentina
Recruiting - Instituto de Oncologia de Rosario
Rosario, Santa Fe Province, Argentina
Recruiting - Sanatorio Parque
Rosario, Santa Fe Province, Argentina
Recruiting - Local Institution - 007-5002
Buenos Aires, Argentina
Not, yet, recruiting - Local Institution - Unk053
Buenos Aires, Argentina
Not, yet, recruiting - Instituto Oncologico de Cordoba (ionc)
Córdoba, Argentina
Recruiting - Local Institution - Unk033
Porto Alegre, Argentina
Active, not recruiting - Local Institution - Unk020
Río Cuarto, Argentina
Active, not recruiting - Local Institution - 007-433
Viedma, Argentina
Not, yet, recruiting
- Ballarat Regional Integrated Cancer Center
Ballarat, Australia
Recruiting - Flinders Medical Centre
Bedford Park, Australia
Recruiting - Local Institution - 007-004
Clayton, Australia
Withdrawn - Canberra Hospital
Garran, Australia
Recruiting - Icon Cancer Centre
Hyde Park, Australia
Recruiting - Port Macquarie Base Hospital
Port Macquarie, Australia
Recruiting - Cancer Care Wollongong
Wollongong, Australia
Recruiting - Princess Alexandra Hospital
Woolloongabba, Australia
Recruiting
- Klinikum Klagenfurt Am Worthersee
Klagenfurt, Austria
Recruiting - Universitatsklinikum Krems
Krems, Austria
Recruiting - Ordensklinikum Linz Elisabethinen
Linz, Austria
Recruiting - Medizinische Universitat Wien
Vienna, Austria
Recruiting - Wiener Gesundheitsverbund - Klinik Floridsdorf
Vienna, Austria
Recruiting - Wiener Gesundheitsverbund - Klinik Hietzing
Vienna, Austria
Recruiting
- Universitair Ziekenhuis Antwerpen
Edegem, Belgium
Recruiting - Algemeen Ziekenhuis Maria Middelares
Ghent, Belgium
Recruiting - Jessa Ziekenhuis - Campus Virga Jesse
Hasselt, Belgium
Recruiting - Local Institution - 007-152
Roeselare, Belgium
Withdrawn
- Local Institution - 007-5050
Salvador, Estado de Bahia, Brazil
Not, yet, recruiting - Liga Contra O Cancer - Centro Avancado de Oncologia
Natal, Rio Grande do Norte, Brazil
Recruiting - Local Institution - Unk050
Lajeado, Rio Grande do Sul, Brazil
Active, not recruiting - Local Institution - 007-5052
Porto Alegre, Rio Grande do Sul, Brazil
Not, yet, recruiting - Local Institution - Unk015
Porto Alegre, Rio Grande do Sul, Brazil
Active, not recruiting - Local Institution - 007-5051
Florianópolis, Santa Catarina, Brazil
Not, yet, recruiting - Fundacao Pio Xii - Hospital de Cancer de Barretos - Hospital de Amor
Barretos, Brazil
Recruiting - Local Institution - Unk060
Barretos, Brazil
Active, not recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 2 Dec 2020
- Primary completion
- 31 Oct 2028
- Completion
- 31 Oct 2029
- Last update posted
- 9 Jul 2026
- Registered enrollment
- 626
- Registry id
- NCT04613596
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.